parasitic%20infections
PARASITIC INFECTIONS
Gastrointestinal parasitic infection symptoms include abdominal pain, diarrhea, dysentery, flatulence, malabsorption and symptoms of biliary obstruction.
It can be caused by protozoan parasites and helminths.
Host susceptibility factors in gastrointestinal parasitic infections are nutritional status, intercurrent disease, pregnancy, immunosuppressive drugs and presence of a malignancy.
Knowledge of the geographic distribution of parasites is helpful in the diagnosis of patients.

Introduction

  • Parasites presents a continual & unacceptable threat to the well-being of millions of people in the tropics, subtropics, as well w/ domesticated animals
  • As more parasites are identified & implicated as a cause of disease, its life cycle elucidated, its control or eradication would follow w/ the development of drugs, vaccines & antivector measures

Signs and Symptoms

Gastrointestinal (GI)

  • Abdominal pain, diarrhea, dysentery, flatulence, malabsorption, symptoms of biliary obstruction

Nonspecific

  • Fever, malaise, fatigue, anorexia, sweating, weight loss, edema & pruritus
  • Some patients may be asymptomatic

Risk Factors

Host Susceptibility Factors in Gastrointestinal (GI) Parasitic Infections

  • Nutritional status
  • Intercurrent disease
  • Pregnancy
  • Immunosuppressive drugs
  • Presence of a malignancy
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, Yesterday
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
6 days ago
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
4 days ago
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.